Massimiliano C.
- Country
- Italy
- Department
- Neurologia B
Research Overview
- A Randomized, Double-Blind Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
- Evaluation of Ocrelizumab Efficacy and Safety in Progressive Multiple Sclerosis: A 4-Year Open-Label, Single-Arm Study
- Evaluation of Ozanimod on Meningeal Inflammation and Glial Activation in Relapsing Multiple Sclerosis: A Phase 4 Study
Data & Insights
Has run more than one trial at 30 of 138 partner sites.
Specializations
Multiple Sclerosis Research
The investigator specializes in studying various forms of multiple sclerosis, with particular emphasis on both progressive MS and relapsing forms of the condition.
- Progressive Multiple Sclerosis Management
- Relapsing Multiple Sclerosis Treatment
- Secondary Progressive MS Interventions
Their research encompasses novel therapeutic approaches for managing different MS manifestations.
Neuroimaging Studies
The investigator focuses on advanced neuroimaging techniques in MS diagnosis and monitoring, particularly examining paramagnetic rim lesions and MRI-based assessments.
- MRI Lesion Analysis
- Neurological Imaging Biomarkers
- Radiologically Isolated Syndrome
Their work integrates imaging technologies to track disease progression and treatment response.
Neuroimmunology
The investigator explores neuroinflammatory processes, with specific attention to meningeal inflammation and glial activation in multiple sclerosis.
- Compartmentalized Inflammation
- CSF Biomarker Analysis
- Immunological Mechanisms
Their research examines the role of inflammatory processes in neurological disease progression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.